Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tang Capital Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 5
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 3
Key employees 5

Areas of investment

  • Biotechnology
  • Health Care
  • Clinical Trials
  • Image Recognition
  • Medical
Summary

The typical case for the fund is to invest in rounds with 4 participants. Despite the Tang Capital Management, startups are often financed by ProQuest Investments, Fonds de solidaritu00e9 FTQ, Adams Street Partners. The meaningful sponsors for the fund in investment in the same round are Adams Street Partners, Venrock Healthcare Partners, Tavistock Life Sciences. In the next rounds fund is usually obtained by Next47, Ampersand Capital Partners, Adams Street Partners.

The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2013. The top activity for fund was in 2019. This Tang Capital Management works on 21 percentage points more the average amount of lead investments comparing to the other organizations.

We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight MethylGene, RadPharm, Attune Pharmaceuticals. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

We also calculated 5 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Tang Capital Management:
Typical Co-investors
Tang Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Tang Capital Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
C4D Partners Amsterdam, Noord-Holland, The Netherlands
Egis Technology Taipei, Taiwan
Hunan Hi-Tech Venture Capital China, Fujian, Hunan
Innogy Venture Capital Essen, Germany, Nordrhein-Westfalen
IXcore France, Ile-de-France, Marly-le-roi
Lanqi Investment -
Menterra Venture Advisors Bengaluru, India, Karnataka
National Cancer Institute SBIR Development Center -
NGP Energy Capital Management Irving, Texas, United States
Pod Investment Stockholm, Stockholm County, Sweden
RIMU Group Central, Central Region, Singapore
Shanda Capital China, Shanghai
SigmaLabs Israel, Ramat Gan, Tel Aviv
stakefish Seoul, Seoul-t'ukpyolsi, South Korea
Swissfirst Bank AG Switzerland, Zürich, Zurich
Vesbridge Partners Massachusetts, United States, Wakefield
WestView Capital Partners Boston, Massachusetts, United States
Yamas Ventures GmbH -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Attune Pharmaceuticals

Biotechnology
$23M23 Jan 2019 New York, New York, United States

RadPharm

Health Care
Image Recognition
Medical
$10M28 Nov 2007 Belconnen, Australian Capital Territory, Australia

RadPharm

Health Care
Image Recognition
Medical
$8M01 Mar 2006 Belconnen, Australian Capital Territory

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tang Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 27M
Peak activity year 2012
Lead investments 1
Follow on index 0.17
Exits 3
Group Appearance index 0.83

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Attune Pharmaceuticals

Biotechnology
$23M23 Jan 2019 New York, New York, United States

RadPharm

Health Care
Image Recognition
Medical
$10M28 Nov 2007 Belconnen, Australian Capital Territory, Australia

RadPharm

Health Care
Image Recognition
Medical
$8M01 Mar 2006 Belconnen, Australian Capital Territory
Crunchbase icon

Content report

The following text will be sent to our editors: